Alliance Pharma PLC Fundamentals Datasheet and Stock Analysis


Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

  • Current Price:
  • Industry:
     Health Care
  • Sector:
     Health Care
  • ISIN:
  • Market Sector:
  • Main Indices:
  • Country of register:
     Great Britain
  • Currency:
  • Shares in Issue:
  • Market Cap:
  • Date Listed:
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)


Activity Data Not Available

Company Information

CEO: Peter Butterfield  Finance Director: Andrew Franklin  Non-Executive Director: John Dawson, Thomas Theodore Casdagli Nigel Clifford  Non-Executive Chairman: David Cook  Company Secretary: Rob Bellhouse  

Composite Ranking: 94
Historic EPS Ranking: 80
Forecast EPS Ranking: 34
Price Relative Strength: 74
Industry Strength: E
SMR Ranking: A
ROCE Ranking: A
Mkt Accumulation/Dist: B
Unbroken Annual EPS: C
Unbroken Interim EPS: C
PEG Current Ranking: B
PEG Forecast Ranking: A
PE Current Ranking: D
PE Forecast Ranking: D
Margin Current Ranking: B
Margin Forecast Ranking: B
Add Indicator


Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Operating Profit/(loss)£m12.3412.3213.3610.8516.7725.3130.16£m0.000.00
Profit Before Tax£m10.7110.8112.0110.1615.1822.2228.37£m27.9731.05
Profit After Tax£m8.648.699.588.3812.6918.0928.91£m0.000.00
Profit After Tax (from discontinued operations)£m0.£m0.000.00
Overall Profit for the Period£m8.648.699.588.3812.6918.0928.91£m0.000.00
EPS Growth%(28.60)(0.28)1.94(14.13)43.99(16.04)57.85%(12.00)10.00
Earnings Per Sharep3.623.613.683.164.553.826.03p4.685.15
Op. Cash Flow P/Sp3.854.710.£0.000.00
Cash Flow P/S Grth%(39.56)22.34(100.00)
Net Cash Flow P/Sp0.£0.000.00
Capital Exp P/S££0.000.00
Tax Rate%
P/E Ratiox8.508.8010.6011.209.4012.3011.00x17.1015.60
P/E Growth££(1.40)1.50
Turnover Per Share£17.4017.£0.000.00
Pre-Tax Profit / Share££0.000.00
Operating Margin%0.0027.4429.5124.9234.6925.9629.19%0.000.00
Mkt Cap£m145.98150.82192.54168.18207.99225.23319.12£m0.000.00
Dividend Per Sharep0.750.820.911.
DPS Growth%31.5810.000.0010.1310.0010.0010.00%0.000.00
Dividend Yield%2.402.602.202.802.502.602.00%1.802.00
Dividend Coverx4.834.384.213.363.203.184.01x0.000.00
Shareholder Funds£m44.1351.8564.6770.78162.44179.26203.38£m0.000.00
Net Borrowings£m(1.08)(4.63)(0.69)(1.43)(3.23)(7.22)(11.18)£m0.000.00
Net Assets£m44.1351.8564.6770.78162.44179.26203.38£m0.000.00
Net Assets P/S££0.000.00
Latest Forecast
Div Yield1.5%1.7%
Div Cover4.0%3.2%
Op Margin29.2%23.8%
Director Deals
Traded Action Notifier Price Amount Value
14-Feb-17SellPeter Butterfield48.75p 61,846£30,149.93
14-Feb-17Exercise of optionPeter Butterfield33.25p 90,222£29,998.82
27-Oct-16Exercise of optionAndrew Franklin47.50p 400,000£190,000
27-Oct-16Exercise of optionPeter Butterfield47.50p 200,000£95,000
27-Oct-16Exercise of optionAndrew Franklin47.50p 155,000£73,625
22-Sep-16SellJohn Dawson45.25p 3,000,000£1,357,499.96
03-May-16BuyDavid Cook46.54p 54,492£25,360.58
03-May-16BuyDavid Cook46.52p 47,879£22,273.31
22-Dec-15BuyNigel Clifford44.95p 66,740£29,999.63
17-Dec-15BuyAndrew L Smith41.00p 75,000£30,750
First PagePrev PageNext Page  Rows per page
475m    Major: 33%    Director: 12%
Notifier Holding Value
John Dawson56,576,402£48,655,705.72
Andrew Franklin400,000£344,000
Nigel Clifford180,663£155,370.18
David Cook102,371£88,039.06
Peter Butterfield28,376£24,403.36
  Rows per page
Gearing & Cover
News Title Date Time Source
Notification of Major Holdings16-May-1815:05RNS
Total Voting Rights02-May-1812:32RNS
Annual Report and AGM Notice19-Apr-1817:25RNS
Notification of Major Holdings19-Apr-1816:59RNS
Disposal of Chinese rights to Forceval17-Apr-1807:00RNS
Alliance to present at the UK Investor Show13-Apr-1807:00RNS-R
Total Voting Rights03-Apr-1816:09RNS
Full Year Results27-Mar-1807:00RNS
Total Voting Rights06-Mar-1813:48RNS
Directorate Changes01-Mar-1807:00RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change
27-May-15Numis SecuritiesAdd43.75p0.00p48.00pDownGrade
26-Mar-15Canaccord GenuityBuy34.38p37.00p40.00pReiteration
19-Jun-13Investec SecuritiesHold36.38p35.20p35.80pDownGrade
06-Jun-13Nplus1 BrewinHold37.25p37.00p37.00pReiteration
12-Sep-12Peel Hunt LimitedHold25.50p24.00p25.60pReiteration
16-Jan-12Brewin DolphinHold28.75p33.00p31.00pDownGrade
17-Nov-11Collins StewartBuy29.50p0.00p36.00pNew Coverage
  Rows per page

This functionality requires you to login

Click here to login
Or register for a new account